Business
Olezarsen significantly reduces triglycerides and acute pancreatitis events in landmark pivotal studies for people with severe hypertriglyceridemia (sHTG)
– Up to 72%
About this update from Ionis Pharmaceuticals, Inc.
[{"type":"text","content":"\n– Up to 72% (p","length":80,"tagName":"div"}]